prioritize likely causal relationships. The major challenges preventing estimation of genetic correlation from genomewide association study (GWAS) data with current methods are the lack of availability of individual-level genotype data and widespread sample overlap among meta-analyses. We circumvent these difficulties by introducing a techniquecross-trait LD Score regression-for estimating genetic correlation that requires only GWAS summary statistics and is not biased by sample overlap. We use this method to estimate 276 genetic correlations among 24 traits. The results include genetic correlations between anorexia nervosa and schizophrenia, anorexia and obesity, and educational attainment and several diseases. These results highlight the power of genome-wide analyses, as there currently are no significantly associated SNPs for anorexia nervosa and only three for educational attainment.
Identifying genetic correlations between complex traits and diseases can provide useful etiological insights and help
prioritize likely causal relationships. The major challenges preventing estimation of genetic correlation from genomewide association study (GWAS) data with current methods are the lack of availability of individual-level genotype data and widespread sample overlap among meta-analyses. We circumvent these difficulties by introducing a techniquecross-trait LD Score regression-for estimating genetic correlation that requires only GWAS summary statistics and is not biased by sample overlap. We use this method to estimate 276 genetic correlations among 24 traits. The results include genetic correlations between anorexia nervosa and schizophrenia, anorexia and obesity, and educational attainment and several diseases. These results highlight the power of genome-wide analyses, as there currently are no significantly associated SNPs for anorexia nervosa and only three for educational attainment.
Understanding the complex relationships among human traits and diseases is a fundamental goal of epidemiology. Randomized controlled trials and longitudinal studies are time-consuming and expensive, so many potential risk factors are studied using cross-sectional correlation studies performed for a single time point. Obtaining causal inferences from such studies can be challenging because of issues such as confounding and reverse causation, which can lead to spurious associations and mask the effects of real risk factors 1, 2 . Genetics can help elucidate cause and effect, as inherited genetic risks cannot be subject to reverse causation and are correlated with a smaller list of confounders.
The first methods to test for genetic overlap were family studies [3] [4] [5] [6] [7] . To estimate the genetic overlap for many pairs of phenotypes, family study designs require the measurement of multiple traits for the same individuals. Consequently, it is challenging to scale these designs to a large number of traits, especially traits that are difficult or costly to measure (for example, low-prevalence diseases). More recently, GWAS have allowed effect size estimates to be obtained for specific genetic variants, so it is possible to test for shared genetics by looking for correlations in effect sizes across traits, which does not require measuring multiple traits per individual.
There exists a large class of methods for interrogating genetic overlap via GWAS that focus only on genome-wide significant SNPs. One of the most influential methods in this class is Mendelian randomization, which uses significantly associated SNPs as instrumental variables to attempt to quantify causal relationships between risk factors and disease 1, 2 . Methods that focus on significant SNPs are effective for traits where there are many significant associations that account for a substantial fraction of heritability 8, 9 . For many complex traits, heritability is distributed over thousands of variants with small effects, and the proportion of heritability accounted for by significantly associated variants at current sample sizes is small 10 . In such situations, one can often obtain more accurate results by using genome-wide data rather than data for only significantly associated variants 11 .
A complementary approach is to estimate genetic correlation, which considers the effects of all SNPs, including those that do not reach genome-wide significance (Online Methods). The two main existing techniques for estimating genetic correlation from GWAS data are restricted maximum likelihood (REML) [11] [12] [13] [14] [15] [16] and polygenic scores 17, 18 . These methods have only been applied to a few traits because they require individual-level genotype data, which are difficult to obtain owing to informed consent limitations.
To overcome these limitations, we have developed a technique for estimating genetic correlation using only GWAS summary statistics that is not biased by sample overlap. Our method, cross-trait LD Score An atlas of genetic correlations across human diseases and traits regression, is a simple extension of single-trait LD Score regression 19 and is computationally very fast. We apply this method to data from 24 GWAS and report genetic correlations for 276 pairs of phenotypes, demonstrating shared genetic bases for many complex traits and diseases.
RESULTS

Overview of the methods
The method presented here for estimating genetic correlation from summary statistics relies on the fact that the GWAS effect size estimate for a given SNP incorporates the effects of all SNPs in linkage disequilibrium (LD) with that SNP 19, 20 . For a polygenic trait, SNPs with high LD will have higher χ 2 statistics on average than SNPs with low LD 19 . A similar relationship holds if we replace the χ 2 statistics for a single study with the product of the z scores from two studies of traits with nonzero genetic correlation.
More precisely, under a polygenic model 11, 13 , the expected value of z 1j z 2j for a SNP j is
where N i is the sample size for study i,  g is the genetic covariance (defined in the Online Methods),  j is the LD Score 19 , N S is the number of individuals included in both studies and  is the phenotypic correlation among the N S overlapping samples. We derive this equation in the Supplementary Note. If study 1 and study 2 are the same study, then equation (1) reduces to the single-trait result from ref. 19 , as the genetic covariance between a trait and itself is heritability, and χ 2 = z 2 . As a consequence of equation (1), we can estimate genetic covariance using the slope from the regression of z 1j z 2j on LD Score, which is computationally very fast (Online Methods). Sample overlap creates spurious correlation between z 1j and z 2j , which inflates z 1j z 2j . The expected magnitude of this inflation is uniform across all markers and in particular does not depend on LD Score. As a result, sample overlap only affects the intercept from this regression (the term N N N s / 1 2 ) and not the slope, so the estimates of genetic correlation will not be biased by sample overlap. Similarly, shared population stratification will alter the intercept but have minimal impact on the slope because the correlation between LD Score and the rate of genetic drift is minimal 19 . If we are willing to assume no shared population stratification and we know the amount of sample overlap and phenotypic correlation in advance (that is, the true value of N N N s / 1 2 ), we can constrain the intercept to this value. We refer to this approach as constrained-intercept LD Score regression. Constrained-intercept LD Score regression has lower standard error, often by as much as 30%, than LD Score regression with an unconstrained intercept but will yield biased and misleading estimates if the intercept is misspecified, for example, if we specify the wrong value of N s or do not completely control for population stratification.
Normalizing genetic covariance by SNP heritabilities yields genetic correlation: r
where h i 2 denotes the SNP heritability 11 from study i. Genetic correlation ranges between −1 and 1. Results similar to equation (1) hold if one or both studies are case-control studies, in which case, genetic covariance is on the observed scale. Details are provided in the Supplementary Note. There is no distinction between observed-and liability-scale genetic correlation for case-control traits, so we can define and estimate the genetic correlation between a case-control trait and a quantitative trait and
the genetic correlation between pairs of case-control traits without the need to specify a scale (Supplementary Note).
Simulations
We performed a series of simulations to evaluate the robustness of the model to potential confounders such as sample overlap and model misspecification and to verify the accuracy of the standard error estimates (Online Methods).
Cross-trait LD Score regression estimates and standard errors from 1,000 simulations of quantitative traits are shown in Table 1 . For each simulation replicate, we generated 2 phenotypes for each of 2,062 individuals in our sample by drawing effect sizes for approximately 600,000 SNPs on chromosome 2 from a bivariate normal distribution. We then computed summary statistics for both phenotypes and estimated heritability and genetic correlation with cross-trait LD Score regression. The summary statistics were generated from completely overlapping samples. These simulations confirm that cross-trait LD Score regression yields accurate estimates of the true genetic correlation and that the standard errors match the standard deviation across simulations. Thus, cross-trait LD Score regression is not biased by sample overlap, in contrast to estimation of genetic correlation via polygenic risk scores, which is biased in the presence of sample overlap 18 . We also evaluated simulations with one quantitative trait and one case-control trait and show that cross-trait LD Score regression can be applied to binary traits and is not biased by oversampling of cases (Supplementary Table 1 ).
Estimates of heritability and genetic covariance can be biased if the underlying model of genetic architecture is misspecified, for example, if the variance explained is correlated with LD Score or minor allele frequency (MAF) 19, 21 . Because genetic correlation is estimated as a ratio, it is more robust; biases that affect the numerator and the denominator in the same direction tend to cancel. We obtained approximately correct estimates of genetic correlation, even in simulations with models of genetic architecture where our estimates of heritability and genetic covariance were biased (Supplementary Table 2 ).
Replication of psychiatric cross-disorder results
As technical validation, we replicated the estimates of genetic correlation among psychiatric disorders obtained with individual-level genotype data and REML 14 by applying cross-trait LD Score regression to summary statistics from the same data 22 . These summary statistics were generated from non-overlapping samples, so we applied crosstrait LD Score regression using both unconstrained and constrained intercepts (Online Methods). The results from cross-trait LD Score regression were similar to the results from REML ( Fig. 1) . Cross-trait LD Score regression with a constrained intercept gave standard errors that were only slightly larger than those from REML, whereas the standard errors from cross-trait LD Score regression with intercept were substantially larger, especially for traits with small sample sizes Estimates represent the average cross-trait LD Score regression estimates across 1,000 simulations; s.d. represents the standard deviation of the estimates across 1,000 simulations, and s.e. represents the mean cross-trait LD Score regression standard error across 1,000 simulations. Further details on the simulation setup are given in the Online Methods.
a N a ly S i S npg a N a ly S i S (for example, attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD)).
Application to summary statistics from 24 phenotypes
We used cross-trait LD Score regression to estimate genetic correlations among 24 phenotypes [23] [24] [25] [26] [27] [28] (see URLs and the Online Methods). The genetic correlation estimates for all 276 pairwise combinations of the 24 traits are shown in Figure 2 . For clarity of presentation, the 24 phenotypes were restricted to include only one phenotype from each cluster of closely related phenotypes (Online Methods). The genetic correlations among the educational, anthropometric, smoking and insulin-related phenotypes that were excluded from Figure 2 are shown in Supplementary Figures 1-4 , respectively. Corresponding references and sample sizes are shown in Supplementary Table 3 .
A full table of the 1,176 genetic correlations among the 49 traits is provided in Supplementary Table 4 .
The first section of Table 2 lists genetic correlation results that are consistent with epidemiological associations but, as far as we are aware, have not previously been reported using genetic data. The estimates of genetic correlation between age at menarche and adult height 29 and between triglyceride levels 30 and type 2 diabetes (T2D) 30, 31 are consistent with epidemiological associations. The estimate of a negative genetic correlation between anorexia nervosa and obesity suggests that the same genetic factors influence normal variation in body mass index (BMI) and dysregulated BMI in psychiatric illness. This result is consistent with the observation that GWAS findings for BMI implicate neuronal rather than metabolic cell types and epigenetic marks 32, 33 . The negative genetic correlation between adult height and coronary artery disease (CAD) agrees with a replicated epidemiological association [34] [35] [36] . We observed several significant associations with the educational attainment phenotypes from Rietveld et al. 37 : we estimated a statistically significant negative genetic correlation between college attendance and Alzheimer's disease, which agrees with epidemiological results 38, 39 . The positive genetic correlation between college attendance and bipolar disorder is consistent with previous epidemiological reports 40, 41 . The estimate of a negative genetic correlation between smoking and college attendance is consistent with observed differences in smoking rate as a function of educational attainment 42 . npg a N a ly S i S The second section of Table 2 lists three results that are, to the best of our knowledge, new both to genetics and epidemiology. One, we found a positive genetic correlation between anorexia nervosa and schizophrenia. Comorbidity for eating and psychotic disorders has not been thoroughly investigated in the psychiatric literature 43, 44 , and this result raises the possibility of similarity between these classes of disease. Two, we estimated a negative genetic correlation between ulcerative colitis and childhood obesity. The relationship between premorbid BMI and ulcerative colitis is not well understood; exploring this relationship may be a fruitful direction for further investigation. Three, we estimated a positive genetic correlation between ASD and educational attainment (which has very high genetic correlation with IQ 37, 45, 46 ). The ASD summary statistics were generated using a case-pseudocontrol study design, so this result cannot be explained by oversampling of ASD cases from more highly educated parents, which is observed epidemiologically 47 . The distribution of IQ among individuals with ASD has a lower mean than the distribution for the general population but with heavy tails 48 (that is, an excess of individuals with low and high IQs). There is also emerging evidence that the genetic architecture of ASD varies across the IQ distribution 49 .
The third section of Table 2 lists interesting examples where the genetic correlation was close to zero with small standard error. The low genetic correlation between schizophrenia and rheumatoid arthritis is interesting because schizophrenia has been observed to be protective for rheumatoid arthritis 50 , although the epidemiological effect is weak; it is thus possible that there is a real genetic correlation but that it was too small for us to detect. The low genetic correlation between schizophrenia and smoking is notable because of the increased tobacco use (in terms of both prevalence and number of cigarettes per day) among individuals with schizophrenia 51 . The low genetic correlation between schizophrenia and plasma lipid levels contrasts with a previous report of pleiotropy between schizophrenia and triglyceride levels 52 . Pleiotropy (unsigned) is different from genetic correlation (signed; Online Methods); however, the pleiotropy reported by Andreassen et al. 52 could be explained by the sensitivity of the method used to the properties of a small number of regions with strong LD rather than trait biology (Supplementary Fig. 5 ). We estimated near-zero genetic correlation between Alzheimer's disease and schizophrenia. The genetic correlations between Alzheimer's disease and other psychiatric traits (anorexia nervosa, bipolar disorder, major depression and ASD) were also close to zero but with larger standard errors, due to smaller sample sizes. This suggests that the genetic basis of Alzheimer's disease is distinct from that for psychiatric conditions. Lastly, we estimated near-zero genetic correlation between rheumatoid arthritis and both Crohn's disease and ulcerative colitis. Although these diseases share many associated loci 53, 54 , there appears to be no directional trend: some rheumatoid arthritis risk alleles are also risk alleles for ulcerative colitis and Crohn's disease, but many rheumatoid arthritis risk alleles are protective for ulcerative colitis and Crohn's disease 53 , yielding near-zero genetic correlation. This example highlights the distinction between pleiotropy and genetic correlation (Online Methods).
Finally, the estimates of genetic correlations among metabolic traits are consistent with the estimates obtained using REML in Vattikuti et al. 15 (Supplementary Fig. 6 ) and are directionally consistent with the recent Mendelian randomization results from Wurtz et al. 55 . The estimate of 0.54 (standard error = 0.07) for the genetic correlation between Crohn's disease and ulcerative colitis is consistent with the estimate of 0.62 (0.04) from Chen et al. 16 .
DISCUSSION
We have described a new method for estimating genetic correlation from GWAS summary statistics, which we apply to a data set of GWAS summary statistics consisting of 24 traits and more than 1.5 million unique phenotype measurements. We report several new findings that would have been difficult to obtain with existing methods, including a positive genetic correlation between anorexia nervosa and schizophrenia. Our method replicated many previously reported GWASbased genetic correlations and confirmed observations of overlap from correlations among genome-wide significant SNPs, Mendelian randomization results and epidemiological associations.
This method is an advance for several reasons: it does not require individual genotypes, genome-wide significant SNPs or LD pruning (which causes loss of information if causal SNPs are in LD). Our method is not biased by sample overlap and is computationally fast. Furthermore, our approach does not require measuring multiple traits for the same individuals, so it scales easily to studies of thousands Results are grouped into genetic correlations that are new genetic results but are consistent with established epidemiological associations ("Epidemiological"), genetic correlations that are new to both genetics and epidemiology ("New/nonzero") and interesting null results ("New/low"). The P values are uncorrected P values. Results that passed multiple-testing corrections for the 300 tests in Figure 2 at an FDR of 1% have a single asterisk; results that passed Bonferroni correction have two asterisks. We present some genetic correlations that agree with epidemiological associations but that did not pass multiple-testing correction in these data. npg a N a ly S i S of pairs of traits. These advantages allow us to estimate genetic correlation for many more pairs of phenotypes than was possible with existing methods. The challenges in interpreting genetic correlation are similar to the challenges in Mendelian randomization. We highlight two difficulties. First, genetic correlation is immune to environmental confounding but is subject to genetic confounding, analogous to confounding by pleiotropy in Mendelian randomization. For example, the genetic correlation between high-density lipoprotein (HDL) levels and CAD in Figure 2 could result from a causal effect HDL → CAD but could also be mediated by triglyceride levels (TG) 9, 56 , represented graphically 57 as HDL ← G → TG → CAD, where G is the set of genetic variants with effects on both HDL and triglyceride levels. Extending genetic correlation to multiple genetically correlated phenotypes is an important direction for future work 58 . Second, although genetic correlation estimates are not biased by oversampling of cases, they are affected by other forms of biased sampling, such as misclassification 14 and case-control-covariate sampling (for example, in a BMI-matched study of T2D).
We note several limitations of cross-trait LD Score regression as an estimator of genetic correlation. First, cross-trait LD Score regression requires larger sample sizes than methods that use individual genotypes to achieve equivalent standard error. Second, cross-trait LD Score regression is not currently applicable to samples from recently admixed populations. Third, we have not investigated the potential impact of assortative mating on estimates of genetic correlation, which remains a future direction. Fourth, methods built from polygenic models, such as cross-trait LD Score regression and REML, are most effective when applied to traits with polygenic genetic architectures. For traits where significant SNPs account for a sizable proportion of heritability, analyzing only these SNPs can be more powerful. Developing methods that make optimal use of both large-effect SNPs and diffuse polygenic signal is a direction for future research.
Despite these limitations, we believe that the cross-trait LD Score regression estimator of genetic correlation will be a useful addition to the epidemiological toolbox because it allows for rapid screening for correlations among a diverse set of traits, without the need for measuring multiple traits on the same individuals or genome-wide significant SNPs. 
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ONLINE METhODS
Definitions of genetic covariance and correlation. All definitions refer to narrow-sense heritabilities and genetic covariances. Let S denote a set of M SNPs, let X denote a vector of additively coded genotypes (0, 1 or 2) for the SNPs in S, and let y 1 and y 2 denote phenotypes. Define b a a :
[ , ] = ∈ argmax Cor R M y X 1 , where the maximization is performed in the population (that is, in the infinite data limit). Let γ denote the corresponding vector for y 2 . The maximizing value of β is the projection of y onto the span of X, so β is unique modulo SNPs in perfect LD. Define h S 2 , the heritability explained by SNPs in S, as SNP genetic correlation (r g ) is different from family study genetic correlation. In a family study, the relationship matrix captures information about all genetic variation, not just common SNPs. As a result, family studies estimate the total genetic correlation (S equals all variants). Unlike the relationship between SNP heritability 11 and total heritability, for which h h g 2 2
≤ , no similar relationship holds between SNP genetic correlation and total genetic correlation. If β and γ are more strongly correlated among common variants than rare variants, then the total genetic correlation will be less than the SNP genetic correlation.
Genetic correlation is (asymptotically) proportional to Mendelian randomization estimates. If we use a genetic instrument 2 . If we use the same set S of SNPs to estimate b 12 and b 21 (for example, if S is the set of all common SNPs, as in the genetic correlation analyses in this report), then this procedure is symmetric in y 1 and y 2 .
Genetic correlation is different from pleiotropy. Two traits have a pleiotropic relationship if many variants affect both. Genetic correlation is a stronger condition than pleiotropy: to exhibit genetic correlation, the directions of effect must also be consistently aligned.
Cross-trait LD score regression. The cross-trait LD Score regression equation is
where z ij denotes the z score for study i and SNPj, N i is the sample size for study i, e g is the genetic covariance,  j is the LD Score 19 , N S is the number of individuals included in both studies and  is the phenotypic correlation among the N S overlapping samples. We derive this equation in the Supplementary Note. We estimate genetic covariance by regressing z 1j z 2j against  j j j N N 1 2 , (where N ij is the sample size for SNP j in study i) and then multiplying the resulting slope by M, the number of SNPs in the reference panel with MAF between 5% and 50% (technically, this is an estimate of the genetic covariance among SNPs with 5-50% MAF; Supplementary Note).
If we know the correct value of the intercept term N N N S / 1 2 ahead of time, we can reduce the standard error by constraining the intercept to this value, using the -constrain-intercept flag in ldsc (for pairs of binary traits, we give corresponding expression in terms of the number of overlapping cases (2) (2) and controls in the Supplementary Note). Note that this works even when there is known nonzero sample overlap.
We recommend using within-sample estimate of  (denoted  ), rather than the population value for  . Under unbiased sampling,  is consistent for  with variance of O(1/N), so, in this case, the distinction between  and  is not of great importance. Under biased sampling, the expected LD Score regression intercept depends on the expected sample correlation E [y i1 y i2 | s = 1] (which is estimated consistently by  ), not the population  value. Thus, we advise that  be used rather than  when constraining the intercept.
Regression weights. For heritability estimation, we use the regression weights from ref. 19 . If effect sizes for both phenotypes are drawn from a bivariate normal distribution, then the optimal regression weights for genetic covariance estimation are: , , , ,   ) that are not known a priori, so it is necessary to estimate them from the data. We compute the weights in two steps:
1. The first regression is weighted using heritabilities from the single-trait LD Score regressions,  N S =0, and  g is estimated as:
The second regression is weighted using the estimates of  N S and  g from step 1. The genetic covariance estimate that we report is the estimate from the second regression.
Linear regression with weights estimated from the data is called feasible generalized least squares (FGLS). FGLS has the same limiting distribution as weighted least squares (WLS) with optimal weights, so WLS P values are valid for FGLS 59 . We multiply the heteroskedasticity weights by 1/ j (where  j is the LD Score summed over regression SNPs) to downweight SNPs that are overcounted. This is a heuristic: the optimal approach is to rotate the data so that they are decorrelated, but this rotation matrix is difficult to compute. Two-step estimator. As noted in ref. 19 , SNPs with very large effect sizes can result in large LD Score regression standard errors for single-trait LD Score regression with an unconstrained intercept; cross-trait LD Score regression with an unconstrained intercept behaves similarly. This is because of the wellknown fact that linear regression deals poorly with outliers in the response variable (LD Score regression with constrained intercept is not nearly as adversely affected by large-effect SNPs). The solution proposed in ref. 19 was to remove SNPs with χ 2 >80 from the LD Score regression. This is a satisfactory solution when the goal is to estimate the LD Score regression intercept. If the goal is to distinguish polygenicity from population stratification and we are willing to assume that the population stratification is subtle, such that SNPs with χ 2 >80 are much more likely to be real causal SNPs than artifacts, then we can make the task much easier by removing these SNPs. However, this is unsatisfactory if the goal is to estimate h 2 : ignoring large-effect SNPs with χ 2 >80 would bias estimates of h 2 and  g toward zero. Therefore, for estimating h 2 or  g , we take a two-step approach. The first step is to estimate the LD Score regression intercept with all SNPs with χ 2 >30 removed (all genome-wide significant SNPs; the threshold can be adjusted with the -two-step flag in ldsc). The second step is to estimate h 2 or  g using all SNPs and constrained-intercept LD Score regression with the intercept constrained to the value from the first step (note that we account for uncertainty in the intercept when computing standard error).
Assessment of statistical significance via block jackknife. Summary statistics for SNPs in LD are correlated, so the ordinary least squares (OLS) standard error will be biased downward. We estimate a heteroskedasticity-and correlation-
npg robust standard error with a block jackknife over blocks of adjacent SNPs. This is the same procedure used in ref. 19 and gives accurate standard errors in simulations ( Table 1) . We obtain the standard error for a genetic correlation by using a ratio block jackknife over SNPs. The default setting in ldsc is 200 blocks per genome, which can be adjusted with the -num-blocks flag.
For the two-step estimator, if we were to estimate the intercept in the first step and then obtain a jackknife standard error in the second step, treating the intercept as fixed, the standard error would be biased downward because it would not take into account the uncertainty in the intercept. Instead, we jackknife both steps of the procedure, which appropriately accounts for uncertainty in the intercept and yields a valid standard error.
Reverse causation. Consider a scenario where a risk factor E 1 causes a disease D, but the incidence of disease D changes postmorbid levels of E 1 (this could occur, for example, if incidence of the disease persuades affected individuals to change their behavior in ways that lower E 1 ). If D is sufficiently common in our GWAS sample, then the genetic correlation may be affected by reverse causation. LD Score regression (or any genetic correlation estimator) will yield a consistent estimate of the cross-sectional genetic correlation between E 1 and D at the given time point; however, the cross-sectional genetic correlation between E 1 and D will be attenuated relative to the genetic correlation between disease and premorbid levels of E 1 . The genetic correlation between disease and premorbid levels of the risk factor will typically be the more interesting quantity to estimate because it is more closely related to the causal effect of E 1 on D. We can estimate this quantity by excluding all postmorbid measurements of the risk factor from the risk factor GWAS. This allows us to circumvent reverse causation, at the cost of a small decrease in sample size. If D is uncommon, then modification of behavior after onset of D will account for only a small fraction of the population variance in E 1 , so the effect of reverse causation on genetic correlation will be small. Thus, reverse causation is primarily a concern for high-prevalence diseases.
Non-random ascertainment. We show in the Supplementary Note that LD Score regression is robust to oversampling of cases in case-control studies, modulo transformation between observed-and liability-scale heritability, and genetic covariance. Oversampling of cases is the most common form of biased sampling, but there are many other forms. For example, consider case-control-covariate ascertainment, where the sampling of cases and controls takes into account a covariate. As a concrete example, we know that high BMI is a major risk factor for T2D. If we wish to discover genetic variants that influence risk for T2D via mechanisms other than BMI, we may wish to perform a case-control study for T2D where we compare BMI-matched cases and controls If we were to use such a T2D study and a random population study of BMI to compute the genetic correlation between BMI and T2D, the result would be substantially attenuated relative to the population genetic correlation between T2D and BMI. (Note that this example holds irrespective of whether there is sample overlap and applies to all genetic correlation estimators, not just LD Score.) More generally, let s i = 1 denote the event that individual i is selected for our study and let C i denote a vector of covariates describing individual i (which may include the phenotype of individual i). We can then represent an arbitrary biased sampling scheme by specifying the selection probabilities as f(C i ): = P[s i = 1 | C i ] (note that case-control ascertainment is the special case where C i = y). Suppose that phenotypes are generated following the model from section 1.1 of the Supplementary Note but that our sample is selected following biased sampling scheme f. Let a ij denote the additive genetic component for phenotype j in individual i. If there is no direct ascertainment on the basis of genotype (that is, if C i does not include genotypes), then the proof of proposition 1 in the Supplementary Note goes through, except that  is replaced by E[y i1 y i2 | s i = 1] and  g is replaced by E[a i1 a i2 | s i = 1]. This has two practical implications: first, in studies with biased sampling schemes and sample overlap, if one wishes to constrain the intercept, one should use the within-sample correlation between phenotypes  rather than the population correlation. Under biased sampling, plim N i i i E y y s →∞ = = [ | ]  1 2 1 , which is typically not equal to  . Second, even if there is no sample overlap, biased sampling can affect estimate of genetic correlation. If the biased sampling mechanism (that is, the function f(C i ): = P[s i = 1 | C i ]) is known, then it may be possible to explicitly model the biased sampling and derive a function to convert genetic correlation estimates from the biased sample to population genetic correlations (similar to the derivations in sections 1.3 and 1.4 of the Supplementary Note). If the biased sampling mechanism can only be described qualitatively, then it should at least be possible to guess the magnitude and direction of the bias by reasoning about E[y i1 y i2 | s i = 1] and E[a i1 a i2 | s i = 1].
